Equality Impact Assessments dated between August 2012 – November
2013

Policy or service being assessed: Neonatal Antimicrobial Policy

Trust Policy for the safe use of McKinley T34 syringe pump in adult
palliative/oncology patients

Policy for use of drugs used outside the terms of their product licence 'Off label' Prescribing

Policy for supply of Payment by Results (PBR) excluded drugs

Policy for New Drug / Product Request

Trust Guideline for Management of Neutropenia in Adults who had
Systemic Anti-Cancer Therapy

Guideline for Antimicrobial Agents in Adults (Antibiotic Guideline)

Policy for the safe preparation of Ganciclovir at ward level

Policy for supply of blood products from pharmacy

Policy for the control of FP10(HP) prescriptions in clinic

Trust Policy Meticilin Resistant Staphylococcus Aureus

Trust Policy for Medicines Reconciliation on Admission of Adults to
Hospital

Trust Policy for the Prevention of IV Related Infections

Policy for Neonatal central line positions

Policy for newborn examinations

Policy or service being assessed: Transitional Care of newborns

Policy or service being assessed: Management of Enteral Tubes

Policy or service being assessed: Antimicrobial policy in neonates

Trust guideline for the management of hypoglycaemia in adults with
diabetes mellitus

Trust Policy for Standards for Oral Anticoagulants (OAs), Vitamin K
Antagonists (VKAs)

Trust Policy for Prescription Charts / Forms

Trust Guideline for The Management of Human Infestations

Trust Guideline for the Management and Control of Viral Haemorrhagic
Fevers

Trust Policy for Last Offices for Infected Patients

Trust Policy for Transmissible Spongiform Encephalopathy (TSE)

Trust Policy for covert administration of medicines for adult patients

Trust Guideline for Meningococcal Infection (Meningitis and
Septicaemia)

Trust Guideline for Infection Control Measures for Patients with
Severe Acute Respiratory Syndrome (SARS)

Trust Policy for the use of potassium chloride injection and intravenous
potassium replacement in adults

Policy or service being assessed: Management of Infants Requiring
Parental Nutrition

Trust Policy for Specimen Collection for Microbiological Analysis

Trust Guideline for use of subcutaneous Metoject (Methotrexate) shared
care guideline for adults who are competent to self-administer

Trust Policy for Infection Prevention & Control in the Operating Theatre

Trust Policy for the Management of Outbreaks of Infection inc. Major
Outbreaks

Trust Policy for supply of medicinal products in prepacks or GSL packs
to patients directly from wards and departments by non-pharmacy staff.

Trust Guideline for The Management of Patients
with an Absent or Dysfunctional Spleen

Trust Guideline for the assessment and management of Acute Kidney
Injury (AKI) in Adults

Trust Policy for Infection Prevention & Control Procedure for In-Patients
with Gastro-Intestinal Infection Including Norovirus Outbreaks

Trust Policy for Management of Linen

Trust Guideline for Parenteral Nutrition in Adults

Trust Policy for Glycopeptide Resistant Enterococci (Gre) Including
Vancomycin Resistant Enterococci (Vre)

Trust Policy for Ward Kitchens and Appliances

Trust policy for Antibiotic Stop Policy for Adults

Trust policy for reducing harm from omitted and delayed critical
medicines

Policy or service being assessed: Management of Acute Kidney Injury
(AKI) in Adults

Policy or service being assessed: Monitoring gentamicin levels on the
neonatal unit

Policy for Developing Trust Documents (Policy of Policies)

Trust Policy for Management of Linen

Trust Guideline for Intravenous Phenytoin Administration in Adults



Trust Guideline for Dabigatran for the Prevention of Stroke and
Systemic Embolism in Patients with Non Valvular AF
Trust Guideline for Rivaroxaban for the Prevention of Stroke and System
Embolism in Patients with Non Valvular AF and for the Treatment of DVT
and PE, and the Prevention of Recurrent DVT and PE in adults

Trust Guideline for the Management of Bleeding in Patients taking
Treatment Doses of a NOAC

Policy or service being assessed: Re-organisation of the Linen Services
Department and the Contract Monitoring Department

Trust Guideline for Ciclosporin Treatment and Monitoring for Patients
with Acute Severe Ulcerative Colitis

Trust Guideline for the management of DKA in adults

Trust Policy for Domestic Abuse Version 2

Trust Policy for Homecare Medicine Services

Trust Policy for Blood Culture Collection

Policy or service being assessed: Suspected Congenital Heart Disease

Policy or service being assessed: Trust Guideline for Vapotherm (HFNC)

Trust Guideline for Enteral Tubes

Policy or service being assessed: Children’s Chronic Fatigue service
changing base from the Lister to the QEII

Trust Policy for Infection Prevention & Control Issues for Staff Health

Trust Policy for Animals in Hospital

Trust Policy for Cleaning and Disinfection for Ophthalmic Equipment in
contact with the Anterior Eye

Rust Isolation Policy

Trust Policy for Norovirus – Infection Control Management of
Gastroenteritis known or suspected to be caused by Norovirus

Trust Policy for Transmissible Spongiform Encephalopathy

Trust Guideline for The Infection Prevention & Control Management of
Chickenpox and Shingles (Varicella-zoster Virus)

Trust Guideline for Risk assessment and Prevention of Venous
Thromboembolism (VTE) in adults (including women attending Obstetric
Clinics).

Trust Guideline for the use of Phosphate.

Trust Policy for Chaperoning Intimate consultations, examinations,
investigations and chaperoning

Trust Guideline for Management of Oral Anticoagulation.

Trust Guideline for Standard Heparin Infusion Schedule for Full
Anticoagulation

Trust Policy and Guidelines on Giving Employment References

Trust Policy for Resuscitation

Trust Policy for Appraisal

Trust Policy for Consent